Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment

Detalhes bibliográficos
Autor(a) principal: Silva Filho, Paulo Sérgio da Paz
Data de Publicação: 2022
Outros Autores: Lemos, Alaíde Silva, Santos, Rosiane Leal dos, Sampaio, Yaskara Raissa de Pádua, Silva, Camila Pinheiro Santiago, Silva, Fernanda Maria, Penha, Ana Alinne Gomes da, Vieira, Larissa Rodrigues, Bastos, Mirla Fernanda Lacerda, Teixeira, Letícia Santos de Carvalho, Marques, Lillian Lettiere Bezerra Lemos, Sezerdo, Maria Clara Cronemberger, Vasconcelos, Brenda Steffane Viana, Chagas, Douglas Bento das, Silva, Thaynara Alves Rodrigues Paulo da, Ribeiro, Maria Gabriela Santos, Farias, Maria Divina dos Santos Borges, Costa, Tom Ravelly Mesquita, Terto, Wesley Douglas da Silva
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/27377
Resumo: The main objective of this study is to review the literature regarding the etiology of erythroblastosis fetalis, emphasizing its physiology. Citing the ways of diagnosing the disease, variations in therapeutic practices over the years and their impact on prognosis. This is an integrative literature review. the following databases were consulted: Medical Publications (PubMed), Scopus (Elsevier), Google Scholar and Scientific Electronic Library Online (SciELO). The following terms were used in the databases: Erythroblastosis fetalis, ABO System, Rh System, Diagnosis and Treatment. Within the time frame from 2017 to 2022. The 19 selected studies addressed are widely discussed, in various aspects, such as the importance of diagnosing DHPN, as well as its prevention. Furthermore, among the selected articles, it is noted that the search for an effective therapy is constant in patients affected by DHPN, showing new discoveries and increasing the available possibilities. From this, it is important to emphasize that new health policies must be implemented in order to minimize the cases of the pathology, such as updating and training courses for all professionals who are directly linked to obstetrics, as well as accessible lectures for the population of old age. fertile in general, prioritizing couples who are expecting their second child.
id UNIFEI_70d1d6be9df55313ff116afeed3d72f3
oai_identifier_str oai:ojs.pkp.sfu.ca:article/27377
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatmentEnfermedad hemolítica del recién nacido (eritroblastosis fetal): del diagnóstico al tratamientoDoença hemolítica do recém-nascido (eritroblastose fetal): do diagnóstico ao tratamentoEritroblastose fetalSistema ABOSistema RhDiagnósticoTratamento.Erythroblastosis fetalisABO SystemRh SystemDiagnosisTreatment.Erythroblastosis fetalisABO SystemRh SystemDiagnosisTreatment.The main objective of this study is to review the literature regarding the etiology of erythroblastosis fetalis, emphasizing its physiology. Citing the ways of diagnosing the disease, variations in therapeutic practices over the years and their impact on prognosis. This is an integrative literature review. the following databases were consulted: Medical Publications (PubMed), Scopus (Elsevier), Google Scholar and Scientific Electronic Library Online (SciELO). The following terms were used in the databases: Erythroblastosis fetalis, ABO System, Rh System, Diagnosis and Treatment. Within the time frame from 2017 to 2022. The 19 selected studies addressed are widely discussed, in various aspects, such as the importance of diagnosing DHPN, as well as its prevention. Furthermore, among the selected articles, it is noted that the search for an effective therapy is constant in patients affected by DHPN, showing new discoveries and increasing the available possibilities. From this, it is important to emphasize that new health policies must be implemented in order to minimize the cases of the pathology, such as updating and training courses for all professionals who are directly linked to obstetrics, as well as accessible lectures for the population of old age. fertile in general, prioritizing couples who are expecting their second child.El objetivo principal de este estudio es revisar la literatura sobre la etiología de la eritroblastosis fetal, haciendo énfasis en su fisiología. Citando las formas de diagnóstico de la enfermedad, las variaciones en las prácticas terapéuticas a lo largo de los años y su impacto en el pronóstico. Esta es una revisión integradora de la literatura. Se consultaron las siguientes bases de datos: Medical Publications (PubMed), Scopus (Elsevier), Google Scholar y Scientific Electronic Library Online (SciELO). En las bases de datos se utilizaron los siguientes términos: Erythroblastosis fetalis, ABO System, Rh System, Diagnosis and Treatment. Dentro del marco temporal de 2017 a 2022. Los 19 estudios seleccionados abordados son ampliamente discutidos, en varios aspectos, como la importancia del diagnóstico de DHPN, así como su prevención. Además, entre los artículos seleccionados, se destaca que la búsqueda de una terapia eficaz es constante en pacientes afectados por DHPN, mostrando nuevos descubrimientos y aumentando las posibilidades disponibles. A partir de ello, es importante destacar que se deben implementar nuevas políticas de salud con el fin de minimizar los casos de la patología, tales como cursos de actualización y capacitación para todos los profesionales que están directamente vinculados a la obstetricia, así como charlas accesibles para la población de vejez fértiles en general, priorizando las parejas que esperan su segundo hijo.O objetivo principal de estudo é revisar a literatura em relação à etiologia da eritroblastose fetal dando ênfase a fisiologia da mesma. Citando as formas de diagnóstico da doença, variações nas práticas terapêuticas ao longo dos anos e seu impacto no prognóstico. Trata-se de uma revisão integrativa da literatura. foram consultadas as seguintes bases de dados: Medical Publications (PubMed), Scopus (Elsevier), Google acadêmico e Scientific Electronic Library Online (SciELO). Foram utilizados os seguintes termos nas bases de dados: Eritroblastose fetal, Sistema ABO, Sistema Rh, Diagnóstico e Tratamento. Dentro do recorte temporal de 2017 a 2022. Os 19 estudos selecionados abordados são amplamente discutidos, em vários aspectos, tais como a importância do diagnóstico da DHPN, como a sua prevenção. Além do mais, dentre os artigos selecionados, nota-se que a busca por uma terapêutica eficaz é constante em pacientes acometidos pelo DHPN, exibindo novas descobertas e ampliando cada vez mais as possibilidades disponíveis. A partir disso, é importante ressaltar que novas políticas de saúde devem ser implantadas visando minimizar os casos da patologia, como por exemplo, cursos de atualização e capacitação para todos profissionais que estejam diretamente ligados à obstetrícia, bem como palestras acessíveis para a população em idade fértil em geral, priorizando casais que estejam esperando seu segundo filho.Research, Society and Development2022-03-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2737710.33448/rsd-v11i4.27377Research, Society and Development; Vol. 11 No. 4; e25911427377Research, Society and Development; Vol. 11 Núm. 4; e25911427377Research, Society and Development; v. 11 n. 4; e259114273772525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/27377/23886Copyright (c) 2022 Paulo Sérgio da Paz Silva Filho; Alaíde Silva Lemos; Rosiane Leal dos Santos; Yaskara Raissa de Pádua Sampaio; Camila Pinheiro Santiago Silva; Fernanda Maria Silva; Ana Alinne Gomes da Penha; Larissa Rodrigues Vieira; Mirla Fernanda Lacerda Bastos; Letícia Santos de Carvalho Teixeira; Lillian Lettiere Bezerra Lemos Marques; Maria Clara Cronemberger Sezerdo; Brenda Steffane Viana Vasconcelos; Douglas Bento das Chagas; Thaynara Alves Rodrigues Paulo da Silva; Maria Gabriela Santos Ribeiro; Maria Divina dos Santos Borges Farias; Tom Ravelly Mesquita Costa; Wesley Douglas da Silva Tertohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva Filho, Paulo Sérgio da Paz Lemos, Alaíde Silva Santos, Rosiane Leal dos Sampaio, Yaskara Raissa de Pádua Silva, Camila Pinheiro SantiagoSilva, Fernanda Maria Penha, Ana Alinne Gomes da Vieira, Larissa RodriguesBastos, Mirla Fernanda LacerdaTeixeira, Letícia Santos de CarvalhoMarques, Lillian Lettiere Bezerra LemosSezerdo, Maria Clara CronembergerVasconcelos, Brenda Steffane VianaChagas, Douglas Bento dasSilva, Thaynara Alves Rodrigues Paulo da Ribeiro, Maria Gabriela SantosFarias, Maria Divina dos Santos BorgesCosta, Tom Ravelly Mesquita Terto, Wesley Douglas da Silva2022-03-27T17:17:09Zoai:ojs.pkp.sfu.ca:article/27377Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:45:08.263832Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment
Enfermedad hemolítica del recién nacido (eritroblastosis fetal): del diagnóstico al tratamiento
Doença hemolítica do recém-nascido (eritroblastose fetal): do diagnóstico ao tratamento
title Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment
spellingShingle Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment
Silva Filho, Paulo Sérgio da Paz
Eritroblastose fetal
Sistema ABO
Sistema Rh
Diagnóstico
Tratamento.
Erythroblastosis fetalis
ABO System
Rh System
Diagnosis
Treatment.
Erythroblastosis fetalis
ABO System
Rh System
Diagnosis
Treatment.
title_short Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment
title_full Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment
title_fullStr Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment
title_full_unstemmed Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment
title_sort Hemolytic disease of the newborn (erythroblastosis fetalis): From diagnosis to treatment
author Silva Filho, Paulo Sérgio da Paz
author_facet Silva Filho, Paulo Sérgio da Paz
Lemos, Alaíde Silva
Santos, Rosiane Leal dos
Sampaio, Yaskara Raissa de Pádua
Silva, Camila Pinheiro Santiago
Silva, Fernanda Maria
Penha, Ana Alinne Gomes da
Vieira, Larissa Rodrigues
Bastos, Mirla Fernanda Lacerda
Teixeira, Letícia Santos de Carvalho
Marques, Lillian Lettiere Bezerra Lemos
Sezerdo, Maria Clara Cronemberger
Vasconcelos, Brenda Steffane Viana
Chagas, Douglas Bento das
Silva, Thaynara Alves Rodrigues Paulo da
Ribeiro, Maria Gabriela Santos
Farias, Maria Divina dos Santos Borges
Costa, Tom Ravelly Mesquita
Terto, Wesley Douglas da Silva
author_role author
author2 Lemos, Alaíde Silva
Santos, Rosiane Leal dos
Sampaio, Yaskara Raissa de Pádua
Silva, Camila Pinheiro Santiago
Silva, Fernanda Maria
Penha, Ana Alinne Gomes da
Vieira, Larissa Rodrigues
Bastos, Mirla Fernanda Lacerda
Teixeira, Letícia Santos de Carvalho
Marques, Lillian Lettiere Bezerra Lemos
Sezerdo, Maria Clara Cronemberger
Vasconcelos, Brenda Steffane Viana
Chagas, Douglas Bento das
Silva, Thaynara Alves Rodrigues Paulo da
Ribeiro, Maria Gabriela Santos
Farias, Maria Divina dos Santos Borges
Costa, Tom Ravelly Mesquita
Terto, Wesley Douglas da Silva
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva Filho, Paulo Sérgio da Paz
Lemos, Alaíde Silva
Santos, Rosiane Leal dos
Sampaio, Yaskara Raissa de Pádua
Silva, Camila Pinheiro Santiago
Silva, Fernanda Maria
Penha, Ana Alinne Gomes da
Vieira, Larissa Rodrigues
Bastos, Mirla Fernanda Lacerda
Teixeira, Letícia Santos de Carvalho
Marques, Lillian Lettiere Bezerra Lemos
Sezerdo, Maria Clara Cronemberger
Vasconcelos, Brenda Steffane Viana
Chagas, Douglas Bento das
Silva, Thaynara Alves Rodrigues Paulo da
Ribeiro, Maria Gabriela Santos
Farias, Maria Divina dos Santos Borges
Costa, Tom Ravelly Mesquita
Terto, Wesley Douglas da Silva
dc.subject.por.fl_str_mv Eritroblastose fetal
Sistema ABO
Sistema Rh
Diagnóstico
Tratamento.
Erythroblastosis fetalis
ABO System
Rh System
Diagnosis
Treatment.
Erythroblastosis fetalis
ABO System
Rh System
Diagnosis
Treatment.
topic Eritroblastose fetal
Sistema ABO
Sistema Rh
Diagnóstico
Tratamento.
Erythroblastosis fetalis
ABO System
Rh System
Diagnosis
Treatment.
Erythroblastosis fetalis
ABO System
Rh System
Diagnosis
Treatment.
description The main objective of this study is to review the literature regarding the etiology of erythroblastosis fetalis, emphasizing its physiology. Citing the ways of diagnosing the disease, variations in therapeutic practices over the years and their impact on prognosis. This is an integrative literature review. the following databases were consulted: Medical Publications (PubMed), Scopus (Elsevier), Google Scholar and Scientific Electronic Library Online (SciELO). The following terms were used in the databases: Erythroblastosis fetalis, ABO System, Rh System, Diagnosis and Treatment. Within the time frame from 2017 to 2022. The 19 selected studies addressed are widely discussed, in various aspects, such as the importance of diagnosing DHPN, as well as its prevention. Furthermore, among the selected articles, it is noted that the search for an effective therapy is constant in patients affected by DHPN, showing new discoveries and increasing the available possibilities. From this, it is important to emphasize that new health policies must be implemented in order to minimize the cases of the pathology, such as updating and training courses for all professionals who are directly linked to obstetrics, as well as accessible lectures for the population of old age. fertile in general, prioritizing couples who are expecting their second child.
publishDate 2022
dc.date.none.fl_str_mv 2022-03-17
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/27377
10.33448/rsd-v11i4.27377
url https://rsdjournal.org/index.php/rsd/article/view/27377
identifier_str_mv 10.33448/rsd-v11i4.27377
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/27377/23886
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 4; e25911427377
Research, Society and Development; Vol. 11 Núm. 4; e25911427377
Research, Society and Development; v. 11 n. 4; e25911427377
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052707572285440